Tirzepatide Weight Loss Injections
US$ 27.92
tirzepatide 4 weeks weight loss Before and After: New Treatment Weight Loss Results after 4
Description
Tirzepatide (Mounjaro for diabetes and Zepbound for obesity, both Eli Lilly), a dual GLP-1/GIP agonist titrated gradually across a broad dosing range, showed a favorable safety profile, with GIP agonism probably buffering GLP-1-mediated fluid shifts, stabilizing vascular tone and reducing ischemic vulnerability
The body is shedding weight quickly, and without adequate nutrition, you risk excessive lean mass loss, micronutrient deficiencies, fatigue, and hair thinning that sometimes accompanies GLP-1 medications
Twenty grams of creatine daily increases gastrointestinal stress
They're both physician-prescribed
